Ensysce Biosciences Inc
ENSC
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.52M
Close$
$1.83
566.1% upside
Current Fair Value
566.1% upsideUndervalued by 566.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.52 Million |
|---|---|
| Enterprise Value | $2.02 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.98 |
| Beta | 0.84 |
| Outstanding Shares | 6,839,385 |
Return
| Return on Equity | 3466.20% |
|---|---|
| Return on Assets | -543.71% |
| Return on Invested Capital | 1763.51% |
Valuation & Multiples
| P/E Ratio | -0.08 |
|---|---|
| PEG | -0.1 |
| Price to Sales | - |
| Price to Book Ratio | -0.28 |
| Enterprise Value to Revenue | 4.09 |
| Enterprise Value to EBIT | -0.17 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | -0.72 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
$-0.73
Average shareholder expectationRevenue Estimate
$1.90 M
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-0.50
Average shareholder expectationRevenue Estimate
$1.90 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Ensysce Biosciences Inc
4 employees